FEMCA Approach to Evaluate Risk Factors on Analytical Procedures of National Drug Sampling and Testing Activites with Mitigation Strategies Research

Xi Hao, Li Rui, Yu Jiandong, Zhu Jiong, Wang Chong, Hu Zengyao

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (1) : 1-17.

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (1) : 1-17. DOI: 10.16153/j.1002-7777.2023.01.001
Supervision Administration

FEMCA Approach to Evaluate Risk Factors on Analytical Procedures of National Drug Sampling and Testing Activites with Mitigation Strategies Research

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 37(1): 1-17 https://doi.org/10.16153/j.1002-7777.2023.01.001

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉